Health & Environmental Research Online (HERO)


Print Feedback Export to File
2223220 
Journal Article 
An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring 
Olsen, GW; Logan, PW; Hansen, KJ; Simpson, CA; Burris, JM; Burlew, MM; Vorarath, PP; Venkateswarlu, P; Schumpert, JC; Mandel, JH 
2003 
Yes 
AIHA Journal
ISSN: 1542-8125 
AMER INDUSTRIAL HYGIENE ASSOC 
FAIRFAX 
64 
651-659 
English 
This investigation randomly sampled a fluorochemical manufacturing employee population to determine the distribution of serum fluorochemical levels according to employees' jobs and work areas. Previous analyses of medical surveillance data have not shown significant associations between fluorochemical production employees' clinical chemistry and hematology tests and their serum PFOS and perfluorooctanoate (PFOA, C(7)F(15)COO(-)) concentrations, but may have been subject to nonparticipation bias. A random sample of the on-site film plant employee population, where fluorochemicals are not produced, determined their serum concentrations also. Of the 232 employees randomly selected for serum sampling, 186 (80%) employees participated (n=126 chemical plant; n=60 film plant). Sera samples were extracted using an ion-pairing extraction procedure and were quantitatively analyzed for seven fluorochemicals using high-pressure liquid chromatography electrospray tandem mass spectrometry methods. Geometric means (in parts per million) and 95% confidence intervals (in parentheses) of the random sample of 126 chemical plant employees were: PFOS 0.941 (0.787-1.126); PFOA 0.899 (0.722-1.120); perfluorohexanesulfonate 0.180 (0.145-0.223); N-ethyl perfluorooctanesulfonamidoacetate 0.008 (0.006-0.011); N-methyl perfluorooctanesulfonamidoacetate 0.081 (0.067-0.098); perfluorooctanesulfonamide 0.013 (0.009-0.018); and perfluorooctanesulfonamidoacetate 0.022 (0.018-0.029). These geometric means were approximately one order of magnitude higher than those observed for the film plant employees. 
biological monitoring; fluorochemicals; organic fluorine; perfluorooctanoate; perfluorooctanesulfonate 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          PubMed
     2-(N-Methylperfluorooctanesulfonamido)acetate
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
     Not prioritized for screening
     Perfluorooctane
     Potassium perfluorooctanoate
     Sodium perfluorooctanoate
     Ethyl perfluorooctanoate
     2-(N-Methylperfluorooctanesulfonamido)acetate
• NMeFOSAA
     Literature Search
          Pubmed
     Screening Results
          Susceptible populations
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFHxS (355-46-4)
          Literature search
               Pubmed
               WOS
     PFOSA (754-91-6)
          Literature Search
               Pubmed
               WOS
     NMeFOSAA (2355-31-9)
          Literature Search
               Pubmed
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               ECHA
     Screened Studies
          Supplemental
     Ammonium perfluorooctanoate
     Perfluorooctane
     Perfluorooctanesulfonamide
     Perfluorooctanesulfonate
     Perfluorooctanesulfonic acid
     Perfluorooctanesulfonyl fluoride
     Perfluorooctanoic acid
• PFBA
     Protocol References
• PFHxS
     Database searches
          Pubmed
          Toxline
          WOS
          Scopus
     Excluded
          TiAb
• PFOSA
     Literature Search
          Pubmed
          WOS
     Screening Results
          Susceptible populations